Cargando…

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma

BACKGROUND: The prognosis of adrenocortical carcinoma (ACC) is heterogeneous. Genomic studies have identified ACC subgroups characterized by specific molecular alterations, including features measured at DNA level (somatic mutations, chromosome alterations, DNA methylation), which are closely associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jouinot, Anne, Lippert, Juliane, Fassnacht, Martin, de La Villeon, Bruno, Septier, Amandine, Neou, Mario, Perlemoine, Karine, Appenzeller, Silke, Sibony, Mathilde, Gaujoux, Sébastien, Dousset, Bertrand, Libe, Rossella, Groussin, Lionel, Ronchi, Cristina L, Assié, Guillaume, Bertherat, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424337/ https://www.ncbi.nlm.nih.gov/pubmed/32698135 http://dx.doi.org/10.1530/EC-20-0228

Ejemplares similares

Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma
por: Jouinot, Anne, et al.
Publicado: (2022)

Preoperative Detection of Liver Involvement by Right-Sided Adrenocortical Carcinoma Using CT and MRI
por: Kedra, Alice, et al.
Publicado: (2021)

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma
por: Espiard, Stéphanie, et al.
Publicado: (2017)

Laparoscopic or Open Adrenalectomy for Stage I–II Adrenocortical Carcinoma: A Retrospective Study
por: Gaillard, Martin, et al.
Publicado: (2023)

MON-LB081 Pituitary Adenomas: A Pan-genomic Classification
por: NEOU, Mario, et al.
Publicado: (2019)

Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the Art
por: Barat, Maxime, et al.
Publicado: (2022)

OR04-3 Genetic Alterations of ARMC5 and KDM1A Are Associated With Different Expression Profiles of Illegitimate Receptors in Primary Bilateral Macronodular Adrenal Hyperplasia
por: Armignacco, Roberta, et al.
Publicado: (2022)

Decreased steroidogenic enzyme activity in benign adrenocortical tumors is more pronounced in bilateral lesions as determined by steroid profiling in LC-MS/MS during ACTH stimulation test
por: Bonnet-Serrano, Fidéline, et al.
Publicado: (2022)

An Ectopic Parathyroid Adenoma Mimicking a Carotid Body Paraganglioma
por: Libé, Rossella, et al.
Publicado: (2020)

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
por: Libé, Rossella
Publicado: (2015)

Identification of glucocorticoid-related molecular signature by whole blood methylome analysis
por: Armignacco, Roberta, et al.
Publicado: (2021)

THU504 Is Carney Complex A Predisposing Syndrome For Breast Cancer? Prospective Study Of 50 Women
por: Vaduva, Patricia, et al.
Publicado: (2023)

Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R
por: Gaujoux, Sébastien, et al.
Publicado: (2013)

OR04-5 Circulating Cell-Free DNA-Based Biomarkers For Prognostication and Disease Surveillance in Adrenocortical Carcinoma
por: Altieri, Barbara, et al.
Publicado: (2022)

EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness
por: Tabbal, Houda, et al.
Publicado: (2019)

Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
por: Lippert, Juliane, et al.
Publicado: (2022)

SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma
por: Smith, Gabrielle, et al.
Publicado: (2020)

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
por: Elhassan, Yasir, et al.
Publicado: (2021)

MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer
por: Garcia, Cyril, et al.
Publicado: (2019)

NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK
por: Cormier, Françoise, et al.
Publicado: (2023)

Evaluation of the Molecular Pathogenesis of Adrenocortical Tumors by Whole-Genome Sequencing
por: Neininger, Kerstin, et al.
Publicado: (2021)

OR12-3 Identification of Predictive Criteria for the Primary Bilateral Macronodular Adrenal Hyperplasia Gene ARMC5: A European Series of 352 Unselected Patients.
por: Assié, Guillaume, et al.
Publicado: (2022)

Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
por: Liang, Raimunde, et al.
Publicado: (2020)

OR08-01 Expression of Gonadal Differentiation Markers in Bilateral Macronodular Adrenocortical Disease
por: De Sousa, Kelly, et al.
Publicado: (2023)

Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas
por: Weigand, Isabel, et al.
Publicado: (2017)

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021)

Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
por: Ko, Ye Lynn, et al.
Publicado: (2023)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
por: Kerdivel, Gwenneg, et al.
Publicado: (2023)

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
por: Buffet, Camille, et al.
Publicado: (2017)

Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study
por: Jouinot, Anne, et al.
Publicado: (2018)

Atypical Presentation of Testicular Adrenal Rest Tumor (TART) Leading to Bilateral Partial Orchiectomy in a 31-Year-Old Adult Revealing Primary Adrenal Insufficiency with CYP11A1 Deficiency
por: Garcia, Cyril, et al.
Publicado: (2021)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
por: Guillaud-Bataille, Marine, et al.
Publicado: (2014)

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma
por: Lefèvre, L, et al.
Publicado: (2015)

Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma
por: Bricaire, Léopoldine, et al.
Publicado: (2017)

What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question
por: Basile, Vittoria, et al.
Publicado: (2021)

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
por: Castro-Vega, Luis Jaime, et al.
Publicado: (2015)

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
por: Ronchi, Cristina L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_larh7aa4la87d56ojgle554m05